Vaccinia virus-mediated high level expression and single step purification of recombinant Jak2 protein

Protein Expression and Purification

Volumn 35, Issue 2, 2004, Pages 181-189

  Ma, Xianyue ^a   Sayeski, Peter P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA; VACCINIA VIRUS;

EID: 2642520559     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2004.02.009     Document Type: Article

References (19)

1. E. Parganas, D. Wang, D. Stravopodis, D.J. Topham, J.C. Marine, S. Teglund, E.F. Vanin, S. Bodner, O.R. Colamonici, J.M. van Deursen, G. Grosveld, J.N. Ihle, Jak2 is essential for signaling through a variety of cytokine receptors, Cell 93 (1998) 385-395.
2. N. Meydan, T. Grunberger, H. Dadi, M. Shahar, E. Arpaia, Z. Lapidot, J.S. Leeder, M. Freedman, A. Cohen, A. Gazit, A. Levitzki, C.M. Roifman, Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor, Nature 379 (1996) 645-648.
3. J. Pan, K. Fukuda, H. Kodama, S. Makino, T. Takahashi, M. Sano, S. Hori, S. Ogawa, Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart, Circ. Res. 81 (1997) 611-617.
4. Y. Seki, H. Kai, R. Shibata, T. Nagata, H. Yasukawa, A. Yoshimura, T. Imaizumi, Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury, Circ. Res. 87 (2000) 12-18.
5. M. Gadina, D. Hilton, J.A. Johnston, A. Morinobu, A. Lighvani, Y.J. Zhou, R. Visconti, J.J. O'Shea, Signaling by type I and II cytokine receptors: ten years after, Curr. Opin. Immunol. 13 (2001) 363-373.
6. C. Schindler, J.E. Darnell Jr., Transcriptional responses to polypeptide ligands: the JAK-STAT pathway, Annu. Rev. Biochem. 64 (1995) 621-651.
7. R.J. Duhé, W.L. Farrar, Characterization of active and inactive forms of the JAK2 protein-tyrosine kinase produced via the baculovirus expression vector system, J. Biol. Chem. 270 (1995) 23084-23089.
8. R.J. Duhé, E.A. Clark, W.L. Farrar, Characterization of the in vitro kinase activity of a partially purified soluble GST/JAK2 fusion protein, Mol. Cell. Biochem. 236 (2002) 23-35.
9. P. Saharinen, K. Takaluoma, O. Silvennoinen, Regulation of the Jak2 tyrosine kinase by its pseudokinase domain, Mol. Cell. Biol. 20 (2000) 3387-3395.
10. Earl et al., Generation of recombinant vaccinia viruses, in: Current Protocols in Molecular Biology, Wiley, New York, 1998, pp. 16.17.1-16.17.19.
11. M.S. Ali, P.P. Sayeski, L.B. Dirksen, D.J. Hayzer, M.B. Marrero, K.E. Bernstein, Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor, J. Biol. Chem. 272 (1997) 23382-23388.
12. B. Moss, Vaccinia virus: a tool for research and vaccine development, Science 252 (1991) 1662-1667.
13. T.R. Fuerst, B. Moss, Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5′ untranslated leader, J. Mol. Biol. 206 (1989) 333-348.
14. P.P. Sayeski, M.S. Ali, A. Safavi, M. Lyles, S.O. Kim, S.J. Frank, K.E. Bernstein, A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn, J. Biol. Chem. 274 (1999) 33131-33142.
15. 231YRFRR, J. Biol. Chem. 276 (2001) 10556-10563.
16. D. VonDerLinden, X. Ma, E.M. Sandberg, K. Gernert, K.E. Bernstein, P.P. Sayeski, Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity, Mol. Cell. Biochem. 241 (2002) 87-94.
17. X. Zhu, Z. Wen, L.Z. Xu, J.E. Darnell Jr, Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase, Mol. Cell. Biol. 17 (1997) 6618-6623.
18. K. Shuai, A. Ziemiecki, A.F. Wilks, A.G. Harpur, H.B. Sadowski, M.Z. Gilman, J.E. Darnell Jr, Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins, Nature 399 (1993) 580-583.
19. A. Stephanou, T.M. Scarabelli, B.K. Brar, Y. Nakanishi, M. Matsumura, R.A. Knight, D.S. Latchman, Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701, J. Biol. Chem. 276 (2001) 28340-28347.